Impact of Antenatal Glucocorticoid Therapy and Risk of Preterm Delivery on Intelligence in Term-Born Children | Zendy

Nina Alexander | Zendy; Franziska Rosenlöcher | Zendy; Lucia Dettenborn | Zendy; Tobias Stalder | Zendy; Julia Linke | Zendy; W. Distler | Zendy; J Morgner | Zendy; Robert Miller | Zendy; Matthias Kliegel | Zendy; Clemens Kirschbaum | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Impact of Antenatal Glucocorticoid Therapy and Risk of Preterm Delivery on Intelligence in Term-Born Children

Author(s) -

Nina Alexander,

Franziska Rosenlöcher,

Lucia Dettenborn,

Tobias Stalder,

Julia Linke,

W. Distler,

J Morgner,

Robert Miller,

Matthias Kliegel,

Clemens Kirschbaum

Publication year - 2015

Publication title -

the journal of clinical endocrinology and metabolism

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.206

H-Index - 353

eISSN - 1945-7197

pISSN - 0021-972X

DOI - 10.1210/jc.2015-2453

Subject(s) - medicine , pregnancy , pediatrics , psychological intervention , premature birth , antenatal steroid , obstetrics , betamethasone , glucocorticoid , gestational age , psychiatry , genetics , biology

Women at risk of preterm delivery are routinely treated with synthetic glucocorticoids (sGCs). Although this therapy substantially reduces neonatal morbidity, concerns remain whether sGC excess may disrupt neurodevelopmental trajectories underlying cognitive functioning.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research